Table 1 Comparison of general data and biological indexes of IFG group and non-IFG group.

From: Prevalence and clinical correlates of impaired fasting blood glucose in children and adolescents with depressive disorder and relationship with triglyceride and high-density lipoprotein ratio

Variable

All patients

(n = 756)

IFG

(n = 49)

Non-IFG

(n = 707)

t/Z/X2

P

Age (years)

14.9 ± 1.8

14.8 ± 1.7

14.9 ± 1.8

− 0.587

0.557 b

Gender (%)

     

 Male

214 (28.3)

24 (49.0)

190 (26.9)

11.034

0.001 c

 Female

542 (71.7)

25 (51.0)

517 (73.1)

  

Education (%)

     

 Primary school

61 (8.1)

4 (8.2)

57 (8.1)

0.439

0.803 c

 Junior middle school

447 (59.1)

31 (63.3)

416 (58.8)

  

 High school or above

248 (32.8)

14 (28.5)

234 (33.1)

  

Age of onset (years)

13.7 ± 2.0

13.3 ± 2.3

13.7 ± 2.0

− 1.205

0.228 b

Age of first admission (years)

14.6 ± 1.9

14.5 ± 1.8

14.7 ± 1.9

− 0.684

0.494 b

Total course of disease (months)

15.2 ± 15.4

18.3 ± 21.7

15.0 ± 14.9

− 0.539

0.590 b

Number of hospitalizations (times)

1.1 ± 0.4

1.2 ± 0.5

1.1 ± 0.4

− 0.540

0.589 b

BMI

21.0 ± 4.1

23.1 ± 5.5

20.9 ± 3.9

− 2.697

0.007 b

Hematological index

     

 FBG (mmol/L)

5.0 ± 0.5

5.9 ± 0.3

5.0 ± 0.5

− 11.552

< 0.001 b

 TG (mmol/L)

1.0 ± 0.6

1.2 ± 0.7

1.0 ± 0.6

− 2.574

0.010 b

 TC (mmol/L)

3.8 ± 0.8

3.8 ± 0.8

3.8 ± 0.8

− 0.234

0.815 a

 HDL-C (mmol/L)

1.5 ± 0.4

1.5 ± 0.5

1.5 ± 0.4

− 0.598

0.550 b

 LDL-C (mmol/L)

2.3 ± 0.6

2.2 ± 0.6

2.3 ± 0.6

− 0.240

0.810 b

 TG / HDL-C

0.7 ± 0.6

0.9 ± 0.6

0.7 ± 0.6

− 2.281

0.023 b

Suicidal ideation (%)

     

 Yes

131 (17.3)

8 (16.3)

123 (17.4)

0.037

0.848 c

 No

625 (82.7)

41 (83.7)

584 (82.6)

  

Attempted suicide (%)

     

 Yes

75 (9.9)

6 (12.2)

69 (9.8)

0.317

0.574 c

 No

681 (90.1)

43 (87.8)

638 (90.2)

  

CGI-S

2.1 ± 0.9

2.1 ± 0.8

2.1 ± 0.9

− 0.150

0.881 b

Antidepressant medications (%)

     

 No

43 (5.7)

6 (12.2)

37 (5.2)

4.913

0.086 c

 Monotherapy

676 (89.4)

42 (85.7)

634 (89.7)

  

 Polypharmacy

37 (4.9)

1 (2.1)

36 (5.1)

  

Antidepressant dosage (mg/d)

27.5 ± 14.7

28.7 ± 12.5

27.5 ± 14.8

− 0.323

0.747 b

Antipsychotic medications (%)

     

 No

429 (56.7)

20 (40.8)

409 (57.9)

5.762

0.056 c

 Monotherapy

309 (40.9)

28 (57.1)

281 (39.7)

  

 Polypharmacy

18 (2.4)

1 (2.1)

17 (2.4)

  

Chlorpromazine equivalent (mg/d)

178.1 ± 124.6

147.2 ± 90.0

181.1 ± 127.2

− 1.414

0.157 b

  1. a: Independent Samples T Test; b: Mann-Whitney U; c: Chi-Square Tests; BMI: body mass index; FBG, fasting blood glucose; TG, triglyceride; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Monotherapy: Taking one kind of antidepressant or antipsychotic medication; Polypharmacy: Taking two kinds of antidepressant or antipsychotic medication.
Back to article page